Opko Health OPK
NASDAQ OPK
$1.73 +0.04 (+2.41%)
As of: Sep 22, 2026 · 10:07 AM EDT

Opko Health (OPK) Cost of Revenue (2010 - 2026)

Opko Health's (OPK) quarterly Cost of Revenue came in at $83.6 million in Q2 2026, down 22.2% on a YoY basis from $107.4 million in Q2 2025, and up 6.53% quarter-over-quarter from $78.4 million in Q1 2026.

Analysis

Opko Health (OPK) Cost of Revenue (2010 - 2026) Analysis & Trends

Opko Health (OPK) has reported Cost of Revenue for 17 consecutive years, with $83.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cost of Revenue fell 22.2% year-over-year to $83.6 million; the trailing twelve-month figure through Jun 2026 stood at $348.2 million (down 60.09% YoY), and the FY2025 full-year result was $400.9 million, down 18.94% from the prior year.
  • Cost of Revenue rose to $83.6 million in Q2 2026 per OPK's latest filing, from $78.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $395.7 million in Q3 2024 and bottomed at $78.4 million in Q1 2026.
  • Historically, Cost of Revenue has averaged $153.7 million across 5 years, with a median of $114.1 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Cost of Revenue soared 271.94% in 2024, then plunged 74.28% in 2025.
  • Over 5 years, Cost of Revenue stood at $194.8 million in 2022, then grew by 8.81% to $211.9 million in 2023, then soared by 86.71% to $395.7 million in 2024, then plunged by 78.66% to $84.4 million in 2025, then slipped by 1.02% to $83.6 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $83.6 million, $78.4 million, and $84.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 8.05 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 4.29 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 4.40 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 3.71 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 4.09 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 3.73 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 3.51 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 174.53 Mn
10 Opko Health 1.25 Bn 945.61 Mn 80.02 Mn 83.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 83.56 Mn
Mar 31, 2026 78.44 Mn
Dec 31, 2025 84.43 Mn
Sep 30, 2025 101.78 Mn
Jun 30, 2025 107.41 Mn
Mar 31, 2025 107.33 Mn
Sep 30, 2024 395.65 Mn
Jun 30, 2024 262.15 Mn
Mar 31, 2024 131.62 Mn
Dec 31, 2023 211.91 Mn
Sep 30, 2023 106.38 Mn
Jun 30, 2023 113.03 Mn
Mar 31, 2023 114.06 Mn
Dec 31, 2022 194.76 Mn
Sep 30, 2022 128.18 Mn
Jun 30, 2022 171.84 Mn
Mar 31, 2022 221.20 Mn
Dec 31, 2021 271.74 Mn
Sep 30, 2021 223.19 Mn
Jun 30, 2021 267.81 Mn
API Access

Opko Health Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=OPK&period=max&api_key=YOUR_API_KEY